SGMO - Sangamo Therapeutics' (SGMO) CEO Sandy Macrae on Q3 2021 Results - Earnings Call Transcript

Sangamo Therapeutics, Inc. (SGMO) Q3 2021 Earnings Conference Call November 4, 2021 9:15 AM ET Company Participants Aron Feingold – Head-Corporate Communications Sandy Macrae – Chief Executive Officer Prathyusha Duraibabu – Chief Financial Officer Bettina Cockroft – Chief Medical Officer Rob Schott – Head-Development Mark McClung – Chief Operating Officer Conference Call Participants Aspen Mori – Bank of America Yanan Zhu – Wells Fargo Luca Issi – RBC Capital Maury Raycroft – Jefferies Nicole Germino – Truist Securities Ritu Baral – Cowen Ben Burnett – Stifel Andreas Argyrides – Wedbush Securities Presentation Operator Thank you all for standing by and welcome to the Sangamo Third Quarter of 2021 Teleconference Call. [Operator Instructions] Please also note that today's call is being recorded. I would now turn the call over to your host Aron Feingold, Head of Corporate Communications. Ma’am, you may now begin. Aron Feingold Good morning and thank you for

For further details see:

Sangamo Therapeutics' (SGMO) CEO Sandy Macrae on Q3 2021 Results - Earnings Call Transcript